stockrow
Friday 6 November 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
302.36
2.54
+0.85%
Follow UFPT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 4 | — |
| 17.82% | 17.17% | 17.05% | 0.00% | ||
| 10.64% | 10.42% | 10.98% | 11.46% | ||
ROIC |
10.44% | 10.15% | 10.29% | 11.20% | |
Return on Tangible Assets |
33.28% | 30.43% | 30.96% | 33.01% | |
Average Days of Receivables |
53.42 | 61.48 | 67.82 | 54.60 | |
Free Cash Flow per Share |
10.26 | 9.01 | 7.95 | 0.00 | |
Free Cash Flow |
79.03 | 69.55 | 61.50 | — | |
Capital Expenditures |
(12.87) | (11.75) | (10.08) | — | |
| Other line items | |||||
Cash ROIC |
13.31% | 11.40% | 10.20% | 0.00% | |
Accounts Receivable Turnover |
6.78 | 6.10 | 6.19 | 7.05 | |
Accounts Payable Turnover |
17.81 | 15.01 | 16.24 | 16.50 | |
Inventory Turnover |
4.96 | 4.75 | 4.88 | 5.01 | |
Average Days of Payables |
20.50 | 23.79 | 26.64 | 20.95 | |
Days of Inventory on Hand |
73.32 | 78.64 | 80.89 | 77.62 | |
Tax Rate |
(0.17) | (0.18) | (0.18) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.85% | 13.10% | 13.27% | 13.53% | |
Share Based Compensation of Revenue |
1.47% | 1.54% | 1.63% | 0.00% | |
Interest Coverage |
9.42 | 10.60 | 12.40 | 14.64 | |
Operating CF/Net income |
1.35 | 1.18 | 0.99 | 0.00 | |
Depreciation/Fixed assets |
0.24 | 0.25 | 0.26 | 0.00 | |
Capex/Depreciation |
(0.67) | (0.60) | (0.51) | — | |
Revenue per Share |
78.23 | 78.86 | 81.61 | 83.85 | |
Operating CF per Share |
11.93 | 10.53 | 9.25 | 0.00 | |
Capex per Share |
(1.67) | (1.52) | (1.30) | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026